Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00738673 | Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer | completed | Phase 2 | 37 | Ferring PharmaceuticalsINDUSTRY | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00014352 | Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00059943 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | completed | Phase 2 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00299741 | Study of SU11248 in Men With Advanced Prostate Cancer | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00564928 | A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer(IPI-504-04) | completed | Phase 2 | 19 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00684905 | Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00084825 | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00080678 | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases | completed | Phase 2 | 116 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 12, 2012 | clinicaltrials |
| NCT00327340 | Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC | completed | Phase 2 | 70 | Achieve Life SciencesINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00284752 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | completed | Phase 2 | 56 | Kaiser PermanenteOTHER | 1 | Oct 1, 2012 | clinicaltrials |
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 2 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00065208 | Reiki/Energy Healing in Prostate Cancer | completed | Phase 1 / Phase 2 | 79 | The Cleveland ClinicOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00617617 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00081601 | Study of CEP-701 in Treatment of Prostate Cancer | completed | Phase 2 | 30 | CephalonINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00752739 | Selenium in Treating Patients With Prostate Cancer | completed | Phase 2 | 220 | University of ArizonaOTHER | 1 | Aug 15, 2012 | clinicaltrials |
| NCT00676780 | Green Tea Extract and Prostate Cancer | completed | Phase 2 | 33 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00512096 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00080808 | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 111 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00027781 | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 37 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 24, 2012 | clinicaltrials |
| NCT00186420 | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation | completed | Phase 2 | 13 | Stanford UniversityOTHER | 1 | Jun 13, 2012 | clinicaltrials |
| NCT00257478 | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | — | Astellas Pharma IncINDUSTRY | 3 | Jun 7, 2012 | clinicaltrials |
| NCT00004045 | Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00031889 | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 | 5 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT01220817 | Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study | completed | Phase 2 | 104 | POM Wonderful LLCINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00653757 | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | completed | Phase 1 / Phase 2 | 100 | Mayo ClinicOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00083005 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | completed | Phase 2 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00242918 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | completed | Phase 2 | 29 | Benaroya Research InstituteOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00116779 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 127 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 19, 2011 | clinicaltrials |
| NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Nov 3, 2011 | clinicaltrials |
| NCT00005857 | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036075 | Study Using CP-461 to Treat Advanced Prostate Cancer | completed | Phase 2 | 25 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00286793 | Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC | completed | Phase 1 / Phase 2 | 76 | Ascenta TherapeuticsINDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00148772 | Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | completed | Phase 2 | 29 | Endeavor HealthOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00050596 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00134654 | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 16, 2011 | clinicaltrials |
| NCT00268593 | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer | completed | Phase 2 | 48 | Progen PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00069888 | A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy | completed | Phase 2 | 83 | SanofiINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00117949 | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 | completed | Phase 2 | 82 | Ferring PharmaceuticalsINDUSTRY | 1 | May 23, 2011 | clinicaltrials |
| NCT00554086 | Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.(CHICS) | completed | Phase 2 | 65 | Canadian Urology Research ConsortiumOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 90 | Groupe D'Etude des Tumeurs Uro-GenitalesOTHER | 1 | May 16, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2013source: clinicaltrials